このエントリーをはてなブックマークに追加
ID 63445
フルテキストURL
著者
Matsumoto, Yoshinori Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Kaken ID researchmap
Dimitriou, Ioannis D. Princess Margaret Cancer Centre, University Health Network, University of Toronto
La Rose, Jose Princess Margaret Cancer Centre, University Health Network, University of Toronto
Lim, Melissa Princess Margaret Cancer Centre, University Health Network, University of Toronto
Camilleri, Susan Centre for Modeling Human Disease, Toronto Centre for Phenogenomics
Law, Napoleon Centre for Modeling Human Disease, Toronto Centre for Phenogenomics
Adissu, Hibret A. Labcorp Early Development Laboratories Inc.
Tong, Jiefei Program in Cell Biology, The Hospital for Sick Children, Department of Molecular Genetics
Moran, Michael F. Program in Cell Biology, The Hospital for Sick Children, Department of Molecular Genetics
Chruscinski, Andrzej Multi-Organ Transplant Program, University Health Network
He, Fang Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Asano, Yosuke Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences ORCID
Katsuyama, Takayuki Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Sada, Ken-ei Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences ORCID Kaken ID researchmap
Wada, Jun Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences ORCID Kaken ID publons researchmap
Rottapel, Robert Princess Margaret Cancer Centre, University Health Network, University of Toronto
抄録
Dysregulation of Toll-like receptor (TLR) signaling contributes to the pathogenesis of autoimmune diseases. Here, we provide genetic evidence that tankyrase, a member of the poly(ADP-ribose) polymerase (PARP) family, negatively regulates TLR2 signaling. We show that mice lacking tankyrase in myeloid cells developed severe systemic inflammation with high serum inflammatory cytokine levels. We provide mechanistic evidence that tankyrase deficiency resulted in tyrosine phosphorylation and activation of TLR2 and show that phosphorylation of tyrosine 647 within the TIR domain by SRC and SYK kinases was critical for TLR2 stabilization and signaling. Last, we show that the elevated cytokine production and inflammation observed in mice lacking tankyrase in myeloid cells were dependent on the adaptor protein 3BP2, which is required for SRC and SYK activation. These data demonstrate that tankyrase provides a checkpoint on the TLR-mediated innate immune response.
発行日
2022-4-1
出版物タイトル
Journal of Clinical Investigation
132巻
7号
出版者
American Society for Clinical Investigation
開始ページ
e140869
ISSN
1558-8238
資料タイプ
学術雑誌論文
言語
英語
OAI-PMH Set
岡山大学
著作権者
© 2022, Matsumoto et al.
論文のバージョン
publisher
PubMed ID
DOI
Web of Science KeyUT
関連URL
isVersionOf https://doi.org/10.1172/jci140869
ライセンス
http://creativecommons.org/licenses/by/4.0/
Citation
Citation Information: J Clin Invest. 2022;132(7):e140869. https://doi.org/10.1172/JCI140869.
助成機関名
Japan Society for the Promotion of Science
助成番号
JP21H02429
JP19H03447
JP21J10565